Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13

Cytokine

Volumn 8, Issue 11, 1996, Pages 822-827

  Osnes, Liv T N ^a   Westvik, Å B ^a   Joo G B ^a   Okkenhaug, C ^a   Kierulf, P ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

IL 1; IL 10; IL 13; IL 4; Tissue factor

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; PROCOAGULANT; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

EID: 0030295230     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0110     Document Type: Article

References (35)

1. 1. McVey JH (1994) Tissue factor pathway. Baillieres Clin Haematol 7:469-484.
2. 2. Ruf W, Edgington TS (1994) Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 8:385-390.
3. 3. Edgington TS, Mackman N, Fan ST, Ruf W (1992) Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Hematol 34 (Suppl): s15-s27.
4. 4. Schwager I, Jungi TW (1994) Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 83:152-160.
5. 5. Weinberg JB, Pippen AM, Greenberg CS (1991) Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheumatol 34:996-1005.
6. 6. Idell S (1994) Extra vascular coagulation and fibrin deposition in acute lung injury. New Horiz 2:556-574.
7. 7. van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Buller HR (1994) Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179:1253-1259.
8. 8. Wada H, Tanigawa M, Wakita Y, Nakase T, Minamikawa K, Kaneko T, Ohiwa M, Kageyama S, Kobayashi T, Noguchi T, Deguchi K, Shirakawa S (1993) Increased plasma level of interleukin-6 in disseminated intravascular coagulation. Blood Coagul Fibrinolysis 4:583-590.
9. 9. Hashimoto Y, Hirohata S, Kashiwado T, Itoh K, Ishii H (1992) Cytokine regulation of hemostatic property and IL-6 production of human endothelial cells. Inflammation 16:613-621.
10. 10. Levi M, ten Cate H, van der Poll T, Deventer SJH (1993) Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975-979.
11. 11. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181.
12. 12. Arend WP, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha rheumatoid arthritis. Arthritis Rheum 38:151-160.
13. 13. Rus HG, Niculescu F, Vlaicu R (1991) Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89: 247-254.
14. 14. Ramshaw AL, Roskell DE, Parums DV (1994) Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol 47:721-727.
15. 15. More L, Sim R, Hudson M, Dhillon AP, Pounder R, Wakefield AJ (1993) Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol 46:703-708
16. 16. Davies MJ (1994) Pathology of arterial thrombosis. Br Med Bull 50:789-802.
17. 17. Leatham EW, Bath PMW, Tooze JA, Camm AJ (1995) Increased monocyte tissue factor expression in coronary disease. Br Heart J 73:10-13.
18. 18. Cavaillon JM (1994) Cytokines and macrophages. Biomed Pharmacother 48:445-453.
19. 19. Ramani M, Ollivier V, Ternisien C, Vu T, Elbim C, Hakim J, De Prost D (1993) Interleukin-4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation. Br J Haematol 85: 462-468.
20. 20. Herbert JM, Savi P, Laplace MC, Lale A, Dol F, Dumas A, Labit C, Minty A (1993) IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328:268-270.
21. 21. Vita N, Lefort S, Laurent P, Caput D, Ferrara P (1995) Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem 270:3512-3517.
22. 22. Ramani M, Ollivier V, Khechai F, Ternisien TV, Bridey F, de Prost D (1993) Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett 334:114-116.
23. 23. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S (1995) High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 171:229-232.
24. 24. Gomez-Jimenez J, Martin MC, Sauri R, Segura RM, Esteban F, Ruiz JC, Nuvials X, Boveda JL, Peracaula R, Salgado A (1995) Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 171:472-475.
25. 25. Brantzseg P, Kierulf P, Gaustad P, Skulberg A, Bruun J, Halvorsen S, Sørensen E (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159: 195-204.
26. 26. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431.
27. 27. Conkling PR, Greenberg CS, Weinberg JB (1988) Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 72:128-133.
28. 28. Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115:457-469.
29. 29. Aderka D (1991) Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications. Isr J Med Sci 27:52-60.
30. 30. Levy GA, Edgington TS (1980) Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med 151: 1232-1244.
31. 31. Levy GA, Schwartz BS, Edgington TS (1981) The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. J Immunol 127:357-363.
32. 32. Herbert JM, Savi P., Laplace MC, Lale A (1992) IL-4 inhibits LPS-, IL-1 beta-and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 310:31-33.
33. 33. Joseph CK, Wright SD, Bornmann WG, Randolph JT, Kumar ER, Bittman R, Liu J, Kolesnick RN (1994) Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biol Chem 269:17606-17610.
34. 34. Osnes LTN, Westvik AB, Kierulf P (1994) Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 76:373-383.
35. 35. Osnes LTN, Westvik ÅB, Øvstebø R, Joø GB, Okkenhaug C, Kierulf P (1995) Lipopolysaccharide activation of human monocytes mediated by CD14 results in a coordinated synthesis of tissue factor, TNF-α and IL-6. J Endotox Res 2:27-35.